Teresa D Borja, Dpm Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 425 Chalan San Antonio, Pmb 1021, Tamuning, GU 96913 Phone: 671-649-3338 Fax: 671-649-3336 |
Dr. Teresa Damian Borja, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 122 Tun Jose Toves Way, Tamuning, GU 96913 Phone: 671-649-3338 Fax: 671-649-3336 |
Dustin B Prins, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 122 Tun Jose Toves Way, Tamuning, GU 96913 Phone: 671-649-3338 |
Dr. Maria Melinda Bernales Sangalang, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 633 Gov Carlos G Camacho Rd, Suite 212, Tamuning, GU 96913 Phone: 671-646-3375 Fax: 671-649-2266 |
News Archive
One minute of radiation in the operating room (OR) could save the lives of thousands of women being treated for breast cancer in the US today. According to a growing body of research, a 60-second course of radiation therapy delivered during surgery dramatically improves results. But, until recently, logistical and administrative difficulties prevented most patients from receiving this crucial treatment until weeks after their procedures.
Researchers at the University of California, Santa Cruz, have developed a novel optical glucose sensor that could be used to provide continuous monitoring of glucose levels in diabetics and hospitalized patients. Recently published studies showed that the sensor detects glucose under physiological conditions, giving a reversible fluorescent signal that changes intensity in response to changes in the concentration of glucose.
Watson Pharmaceuticals, Inc. today confirmed that a jury in the drug pricing litigation trial in the Kentucky Circuit Court for Franklin County rendered a verdict in favor of Watson on all counts in the litigation.
FSC Therapeutics, LLC, today announced that the Company has entered into a transaction with Eisai Inc. to acquire exclusive U.S. marketing rights for AcipHex® Sprinkle™ (rabeprazole sodium), Delayed-Release Capsules, 5 mg and 10 mg, for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks.
Boulder researchers are embarking on a new project to study the progression of neurodegenerative diseases like Alzheimer's by using a new technique to measure neurons firing deep inside animal brains.
› Verified 7 days ago